ZEROSTACK CORP
ZSTKNASDAQTrading Snapshot
- Day Range
- $4.84 β $4.94
- 52-Week Range
- $1.32 β $15.04
- Volume
- $2.61B
- Avg Volume
- $1.90B
- Shares Outstanding
- 1.0M
- Next Earnings
- Oct 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $36M
- Last Q Revenue
- $14M
- P/E Ratio
- -0.0
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-17.85
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +188.0%
Why Investors Own ZSTK
- βHigh-growth profile β revenue up -5.5% YoY with expanding US Equity exposure.
- βHealthy economics β 48% gross margin and 18% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ZEROSTACK CORP
ZSTKAbout ZEROSTACK CORP
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
ZEROSTACK CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ZSTK price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ZEROSTACK CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.